Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autoregulation of glomerular filtration rate under spironolactone treatment in type 1 diabetes
2006-001453-10Phase 4Completed
- Sponsor
- Hans-Henrik Parving
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of spironolactone in hypertension (HTN) and diabetes mellitus type 1 (T1D), sponsored by Hans-Henrik Parving. Primary endpoint: Change in GFR autoregulation with and without spironolactone during acute blood pressure reduction. Started May 2006; status: completed.
02
Drugs
spironolactone
03
Conditions
hypertension (HTN)diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2006-001453-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001453-10.